WSP Global Inc., one of the world’s leading professional services firms, announces the acquisition of Lexica, a UK-based consulting firm specializing in healthcare and life sciences.
Health Technology Insights: Pvolve and Tally Health Partner to Boost Longevity with Science-Backed Movement
Lexica adds 90 UK-based experts to WSP’s Planning, Property and Advisory business in the region, forming a new Healthcare and Life Sciences Advisory team.
The firm focuses on healthcare strategy and planning, property consulting services, cost management, project & program management, life sciences strategy, digital advisory and transformation and Net Zero consulting services.
The addition of Lexica supports WSP’s growth aspirations for advisory services over the next three years—a goal set out in its 2025-2027 Global Strategic Action Plan. This transaction expands WSP’s well-established presence in the healthcare sector and follows WSP’s recent appointment as a consortium partner to the joint venture on the NHS’ New Hospitals Programme (NHP).
Health Technology Insights: Labcorp Expands Oncology Portfolio to Enhance Patient Care and Cancer Research
Alexandre L’Heureux, President and Chief Executive Officer of WSP, said: “The acquisition of Lexica directly supports our strategic objective of strengthening our Advisory capabilities and solidifying our leadership in the healthcare and life sciences sectors. WSP will continue to grow with purpose, expanding our footprint in key regions, strengthening our partnerships, and positioning our combined team for deeper impact in high-value end markets.”
Paul Reilly, President and Managing Director, WSP in the UK and Ireland, said: “The acquisition of Lexica adds significant strength to our expanding UK advisory business. By combining deep sector expertise with a client-first mindset, we are scaling our capabilities to deliver smarter, more integrated solutions. I am excited to welcome our new colleagues and look forward to the opportunities we will create together, united by a shared vision for the future.”
Health Technology Insights: Bionical Emas and Pharma Resources Form Exclusive Global Clinical Trial Supply Partnership
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – GlobalNewswire
